A new study suggests the shingles vaccine may lower the likelihood of developing dementia as well as slow its progression in ...

Semaglutide lowered inflammation, but not cognitive decline ...

The study found that the shingles vaccine could help people who are already diagnosed with dementia ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression ...

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral ...

Previous research suggests the shingles vaccine could reduce dementia risk. A follow up study suggests it may also help slow ...

The shingles vaccine not only offers protection against the painful viral infection, but a new study suggests that the two-dose shot also may slow the progression of dementia.

Results showed that people with obesity had blood biomarkers for Alzheimer’s that rose more rapidly, including: Tau proteins, ...

There is no single, easy test to diagnose Alzheimer’s, but a new review of 18 scientific studies confirms that a simple blood ...

Alzheimer's disease often begins many years before memory problems appear. During that silent phase, toxic changes slowly ...

Obesity could speed up the pathology of Alzheimer's disease as signified by blood biomarkers, suggesting prevention by managing weight loss.